About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
minkabu the infonoid
(C) 2024 MINKABU THE INFONOID, Inc.
kabutan

Carna Biosciences, Inc.(4572) Summary

4572
TSE Growth
Carna Biosciences, Inc.
280
JPY
+1
(+0.36%)
May 1, 2:02 pm JST
1.94
USD
May 1, 1:02 am EDT
Result
PTS
outside of trading hours
280
May 1, 1:57 pm JST
Summary Chart Historical News Financial Result
PER
PBR
2.16
Yield
ー%
Margin Trading Ratio
Stock Price
May 1, 2025
Opening May 1, 9:00 am
279 JPY 1.95 USD
Previous Close Apr 30
279 JPY 1.95 USD
High May 1, 9:22 am
282 JPY 1.97 USD
Low May 1, 9:02 am
275 JPY 1.92 USD
Volume
28,500
Trading Value
8.00M JPY 0.06M USD
VWAP
280.03 JPY 1.95 USD
Minimum Trading Value
28,000 JPY 194 USD
Market Cap
5.35B JPY 0.04B USD
Number of Trades
56
Liquidity & Number of Trades
As of May 1, 2025
Liquidity
Mid
1-Year Average
239
1-Year High Jun 18, 2024
1,774
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 25, 2025 0 1,471,600
Apr 18, 2025 0 1,470,600
Apr 11, 2025 0 1,445,400
Apr 4, 2025 0 1,589,100
Mar 28, 2025 200 1,634,300 8171.50
Company Profile
Carna Biosciences, Inc. specializes in drug discovery support services, primarily focusing on the production and sale of kinase proteins and analysis outsourcing. The company is also expanding into drug discovery.
Sector
Pharmaceuticals
Carna Biosciences, Inc. offers a diverse range of products and services supporting early-stage drug discovery, including the manufacture and sale of kinase proteins, assay development, profiling and screening services, and cell-based assay services. The company's strength lies in its extensive lineup of kinase proteins and assay kits. Additionally, Carna Biosciences is focusing on in-house drug discovery with kinase inhibitors, advancing research and development of new drugs in key disease areas such as cancer and immune-inflammatory disorders. For cancer-related projects, the company plans to conduct studies up to Phase II trials at most, while for other diseases, it aims to carry out Phase I trials or preclinical studies before out-licensing to pharmaceutical companies.